![Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape | Journal of the American Chemical Society Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.1c08226/asset/images/medium/ja1c08226_0004.gif)
Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape | Journal of the American Chemical Society
![Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances](https://www.science.org/cms/10.1126/sciadv.abq8276/asset/fc449466-b0fe-4d9b-882b-c2773408575c/assets/images/large/sciadv.abq8276-f1.jpg)
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances
![Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen: Molecular Therapy Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen: Molecular Therapy](https://www.cell.com/cms/attachment/44330896-4245-4dcf-9bb4-ac9c48dc327b/gr1_lrg.jpg)
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen: Molecular Therapy
![Frontiers | Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model Frontiers | Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model](https://www.frontiersin.org/files/Articles/641447/fimmu-12-641447-HTML/image_m/fimmu-12-641447-g001.jpg)
Frontiers | Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
![Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances](https://www.science.org/cms/10.1126/sciadv.abq8276/asset/56cd15ef-f5ac-4458-9cec-7c8da0a51743/assets/images/large/sciadv.abq8276-f4.jpg)